BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW)

CUSIP: G1125A116

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / *W EXP 11/30/202
Total 13F shares
4,705,860
Share change
+178,712
Total reported value
$670,000
Price per share
$0.09
Number of holders
30
Value change
-$371,466
Number of buys
10
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP G1125A116?
CUSIP G1125A116 identifies BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) as of Q2 2022

As of 30 Jun 2022, BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,705,860 shares. The largest 10 holders included HGC Investment Management Inc., Polar Asset Management Partners Inc., RAMIUS ADVISORS LLC, Corbin Capital Partners, L.P., Q Global Advisors, LLC, KINGSTOWN CAPITAL MANAGEMENT L.P., Shaolin Capital Management LLC, TENOR CAPITAL MANAGEMENT Co., L.P., MMCAP International Inc. SPC, and Arena Capital Advisors, LLC- CA. This page lists 30 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.